NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-070-2020-0-IL-04 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS AND THEIR USE IN HYPERPOLARIZED IMAGING IL National Stage 294464 Pending
NIDDK E-127-2019-0-DE-01 N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION DE EP 20842420.0 Issued
NIDDK E-127-2019-0-FR-01 N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION FR EP 20842420.0 Issued
NIDDK E-127-2019-0-EP-03 N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION EP National Stage 20842420.0 Issued
NIDDK E-127-2019-0-GB-01 N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION GB EP 20842420.0 Issued
NCI E-175-2016-0-EP-19 ANTI-KRAS-G12D T CELL RECEPTORS EP DIV 22182473.3 Pending
NIAID E-197-2023-0-US-02 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US 63/357,873 Expired
NIAID E-131-2015-2-US-50 NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US CON 17/855,553 12202886 Issued PDF
NCI E-199-2023-0-PC-01 TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA PCT PCT PCT/EP2022/068204 Expired
NCI E-199-2023-0-US-02 TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA US ORD 17/854,211 Abandoned
NCI E-129-2022-0-US-01 CD25-SPECIFIC ANTIBODIES AND USES THEREOF US 63/357,215 Expired
NIAID E-197-2023-0-US-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US 63/357,336 Expired
NIAID E-197-2023-1-US-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US 63/357,331 Expired
NIDCR E-186-2019-0-US-05 TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTH US National Stage 17/789,742 12478662 Issued PDF
NIAID E-297-2016-2-US-09 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US CON 17/851,905 12054519 Issued PDF
NCATS E-074-2019-0-US-06 METHOD FOR INHIBITING DENGUE VIRUS INFECTION US CON 17/809,327 11903929 Issued PDF
NCATS E-074-2019-0-US-07 METHOD FOR INHIBITING ZIKA VIRUS INFECTION US CON 17/809,353 11878004 Issued PDF
NCATS E-074-2019-0-US-05 METHOD FOR INHIBITING ZIKA VIRUS INFECTION US CON 17/809,339 11850236 Issued PDF
NCATS E-074-2019-0-US-04 METHOD FOR INHIBITING DENGUE VIRUS INFECTION US CON 17/809,345 11779570 Issued PDF
NEI E-008-2020-0-US-03 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES US National Stage 17/789,729 Pending
NCI E-114-2011-0-US-06 METHODS OF GROWING TUMOR INFILTRATING LYMPHOCYTES IN GAS-PERMEABLE CONTAINERS US CON 17/851,173 Abandoned
NCI E-118-2024-0-US-01 AUGMENTING MITOCHONTIRIA IN T CELLS FOR IMPROVED CANCER LMMUNOTHERAPY US 63/356,456 Expired
NHLBI E-069-2020-0-IL-04 REAL-TIME MONITORING OF IN VIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES IL National Stage 294365 Pending
NIAID E-004-2009-2-US-28 VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE US DIV 17/850,706 11992523 Issued PDF
NCI E-106-2017-0-US-04 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS US CON 17/849,951 Abandoned
NLM E-111-2016-9-US-02 NOVEL CRISPR ENZYMES AND SYSTEMS US DIV 17/848,563 11773412 Issued PDF
NCATS E-147-2022-1-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/355,318 Expired
NCI E-229-2014-0-JP-13 METHODS FOR ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR CANCER SPECIFIC MUTATIONS JP DIV 2022-101099 Issued
NHLBI E-091-2021-0-PCT-02 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE PCT PCT PCT/US2022/034511 Expired
NCATS E-244-2014-0-HK-33 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof HK EP 42022055599.9 Pending
NHLBI E-091-2021-0-EP-01 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE EP National Stage 22743679.7 Pending
NCATS E-146-2022-0-US-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/354,398 Expired
NIAID E-060-2015-0-IL-19 Novel Multivalent Nanoparticle-Based Vaccines IL DIV 294189 Issued
NCI E-174-2018-2-GB-19 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY GB DIV 2209032.8 Issued
NCI E-105-2019-0-US-08 CD206 Modulators Their Use and Methods for Preparation US National Stage 17/787,313 Pending
NCI E-023-2019-0-EP-04 INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS EP National Stage 20824760.1 Issued
NIAID E-001-2024-0-US-01 Viral Strain Serology Assays US 63/353,225 Expired
NIAID E-216-2021-0-PCT-02 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery PCT PCT PCT/US2022/033819 Expired
NIAID E-216-2021-0-TW-04 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery TW ORD 111122464 Pending
NIAID E-153-2019-1-NZ-11 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE NZ National Stage 789242 Pending
NCI E-094-2017-0-AU-01 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment AU DIV 2022204182 Issued
NCI E-205-2010-2-US-22 PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES US CON 17/841,110 Pending
CC E-183-2016-0-HK-18 DETECTION OF PROSTATE CANCER IN MULTI-PARAMETRIC MRI USING RANDOM FOREST WITH INSTANCE WEIGHTING & MR PROSTATE SEGMENTATION BY DEEP LEARNING WITH HOLISTICALLY-NESTED NETWORKS HK EP 42022055182.4 Pending
NCI E-227-2006-5-CA-22 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS CA DIV 3163418 Pending
NIAAA E-110-2022-0-US-01 METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES US 63/352,428 Expired
NCATS E-113-2023-0-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/352,439 Expired
NIDDK E-127-2019-0-US-04 N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4-NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE AND ITS USE FOR TREATING HIV INFECTION US National Stage 17/785,155 12551464 Issued PDF
NIAID E-133-2015-0-CN-12 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE CN DIV 202210669835.0 Issued
NCI E-494-2013-0-US-29 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 17/838,662 11918640 Issued PDF
NHLBI E-155-2016-0-US-05 LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES US CON 17/839,264 Abandoned